Assistant Professor, Global Health
Adjunct Assistant Professor, Epidemiology
Dr. Patricia Pavlinac, MS, PhD, is an epidemiologist and Assistant Professor in the Department of Global Health at the University of Washington. Dr. Pavlinac also co-directs the Gut Health and Child Survival scientific priority area of the Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). Her research aims to identify interventions to halt morbidity and mortality attributed to enteric infectious diseases in children. Dr. Pavlinac has extensive experience coordinating pediatric studies in Kenya including her current role as Project Director of two clinical trials testing whether empiric use of a broad-spectrum antibiotic improves post-acute survival and growth in Kenyan children. These trials build on evidence that Kenyan children suffer an elevated risk of mortality and chronic malnutrition after acute infectious illnesses that may be due to inadequately treated or new exposure to bacterial pathogens. Nested in these trials, her team is also evaluating the impact of azithromycin on antimicrobial resistance to provide policy-makers with a balanced perspective on the costs and benefits of empiric azithromycin use.
Publications
- Rogawski McQuade, ET, Codi, A, Pavlinac, PB, Feutz, E, Kotloff, K, Platts-Mills, JA et al.. Effects of Shigella diarrhea with and without antibiotic treatment on linear growth: an individual patient data meta-analysis of five multisite studies among children in low-resource settings. medRxiv. 2026; :. doi: 10.64898/2026.07.10.26357688. PubMed PMID:42528504 PubMed Central PMC13409227.
- Ahmed, N, Yousafzai, MT, Rao, SI, Means, AR, Pavlinac, PB, Morozoff, C et al.. Exploring risk factors associated with catastrophic health expenditure on diarrhea management in Karachi, Pakistan, 2022-2024. PLOS Glob Public Health. 2026;6 (7):e0005391. doi: 10.1371/journal.pgph.0005391. PubMed PMID:42455800 PubMed Central PMC13372140.
- Oreso, C, Ogwel, B, Awuor, AO, Anyango, RO, Kotloff, K, Hossain, MJ et al.. Frequency and correlates of non-receipt of age-appropriate vaccination among children aged 6-35 months with medically attended diarrhea: Findings from the Enterics for Global Health (EFGH) Shigella study, 2022-2024. PLOS Glob Public Health. 2026;6 (7):e0005670. doi: 10.1371/journal.pgph.0005670. PubMed PMID:42384629 PubMed Central PMC13322521.
- Mategula, D, Conteh, B, McGrath, CJ, Feutz, E, Kotloff, KL, Awuor, AO et al.. The consequences of Shigella medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study. EClinicalMedicine. 2026;97 :104025. doi: 10.1016/j.eclinm.2026.104025. PubMed PMID:42382133 PubMed Central PMC13316610.
- Kariuki, K, Tickell, KD, Kigen, C, Wachira, J, Mogeni, P, Rwigi, D et al.. Fluoroquinolone-resistant Escherichia coli carrying quinolone efflux pump (qepA) with L348-G349 duplication in the absence of V134I substitution. Microbiol Spectr. 2026;14 (8):e0005626. doi: 10.1128/spectrum.00056-26. PubMed PMID:42370683 PubMed Central PMC13435699.